Skip to main content

Table 5 Frequency and percentage of clinical complications among solid organ transplant recipients regarding different therapeutic regimens during the hospitalization period

From: Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?

Medications Complication
Bacterial superinfection; n = 58 Elevated liver enzymes; n = 123 Reduced glomerular filtration rate; n = 31 Neutropenia or thrombocytopenia; n = 29 Cardiovascular; n = 67 Gastrointestinal; n = 93
Hydroxychloroquine 10 (17) 32 (26) 3 (10) 2 (7) 31 (46) 49 (53)
Interferon 11 (19) 24 (20) 2 (6) 1 (3) 1 (1)
Lopinavir/Ritonavir 9 (16) 41 (33) 4 (13) 2 (7) 30 (45) 22 (24)
Remdesivir 7 (12) 11 (9) 12 (39) 4 (14) 9 (10)
Tocilizumab 6 (10) 8 (7) 6 (19) 13 (45) 2 (3) 7 (8)
Dexamethasone or High dose methylprednisolone 15 (26) 7 (6) 4 (13) 7 (24) 4 (6) 5 (5)
P value 0.09 0.11 0.88 1.32 1.09 0.77